Literature DB >> 16339966

Host and parasite-derived IKK activities direct distinct temporal phases of NF-kappaB activation and target gene expression following Toxoplasma gondii infection.

Robert E Molestina1, Anthony P Sinai.   

Abstract

Activation of NF-kappaB by the intracellular pathogen Toxoplasma gondii is associated with the localization of phosphorylated IkappaB alpha to the parasitophorous vacuole membrane (PVM). This is mediated by a parasite-derived IkappaB kinase (TgIKK) activity and is independent of host IKK function. In the present study, we examined the roles of host IKK and parasite-derived TgIKK on the temporal modulation of NF-kappaB activation. Despite the presence of TgIKK activity at the PVM, nuclear translocation of NF-kappaB and subsequent gene expression exhibited a requirement for the host IKK complex. A detailed kinetic analysis of NF-kappaB activation revealed a biphasic, hierarchical and temporally regulated response. We propose a novel paradigm for the modulation of NF-kappaB-dependent gene expression by T. gondii that involves both the host IKK complex and TgIKK activity at different phases of infection. Thus, T. gondii effectively alters gene expression in a temporal dimension by exploiting the NF-kappaB signaling machinery and subsequently rewiring the activation circuits of the infected host cell.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16339966     DOI: 10.1242/jcs.02709

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  30 in total

1.  Quantitative proteomics using stable isotope labeling with amino acids in cell culture reveals changes in the cytoplasmic, nuclear, and nucleolar proteomes in Vero cells infected with the coronavirus infectious bronchitis virus.

Authors:  Edward Emmott; Mark A Rodgers; Andrew Macdonald; Sarah McCrory; Paul Ajuh; Julian A Hiscox
Journal:  Mol Cell Proteomics       Date:  2010-05-13       Impact factor: 5.911

Review 2.  Effects of Toxoplasma gondii infection on the brain.

Authors:  Vern B Carruthers; Yasuhiro Suzuki
Journal:  Schizophr Bull       Date:  2007-02-23       Impact factor: 9.306

3.  Modulation of the host cell proteome by the intracellular apicomplexan parasite Toxoplasma gondii.

Authors:  M M Nelson; A R Jones; J C Carmen; A P Sinai; R Burchmore; J M Wastling
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

Review 4.  Host cell manipulation by the human pathogen Toxoplasma gondii.

Authors:  J Laliberté; V B Carruthers
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

5.  A genome-wide RNA interference screen identifies caspase 4 as a factor required for tumor necrosis factor alpha signaling.

Authors:  Dorothee Nickles; Christina Falschlehner; Marie Metzig; Michael Boutros
Journal:  Mol Cell Biol       Date:  2012-06-25       Impact factor: 4.272

Review 6.  Pathogens hijack the epigenome: a new twist on host-pathogen interactions.

Authors:  Natalie C Silmon de Monerri; Kami Kim
Journal:  Am J Pathol       Date:  2014-02-11       Impact factor: 4.307

Review 7.  Invasion and intracellular survival by protozoan parasites.

Authors:  L David Sibley
Journal:  Immunol Rev       Date:  2011-03       Impact factor: 12.988

8.  The apicomplexan pathogen Neospora caninum inhibits host cell apoptosis in the absence of discernible NF-kappa B activation.

Authors:  Rebecca K Herman; Robert E Molestina; Anthony P Sinai; Daniel K Howe
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

9.  The role of DNA microarrays in Toxoplasma gondii research, the causative agent of ocular toxoplasmosis.

Authors:  Kevin M Brown; Ira J Blader
Journal:  J Ocul Biol Dis Infor       Date:  2009-12-12

10.  Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events.

Authors:  Sónia S Albuquerque; Céline Carret; Ana Rita Grosso; Alice S Tarun; Xinxia Peng; Stefan H I Kappe; Miguel Prudêncio; Maria M Mota
Journal:  BMC Genomics       Date:  2009-06-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.